Sign in
CompletedPhase 3

Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial

Key facts

Who runs it
University of Maryland, College Park
Where
College Park, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 3
People taking part
269 people enrolled
Started
6 Aug 2020
Ended
31 Jul 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Behavioral Parent Training
  • Extended release mixed amphetamine salts (MAS)
Record updated
16 September 2026

Who can take part

Age
3 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Other criteria

  • Child Inclusion Criteria:
  • Be at least 3 years old and no more than 8 years old
  • ADHD medication naive or have not had an adequate trial of stimulant medications
  • Have ≥5 inactivity or ≥5 hyperactivity symptoms rated as 1 or 2 on the Vanderbilt
  • Have a CGI-S-ADHD rating ≥4 and <7; Child Exclusion Criteria:
  • Severe ADHD (CGI-S-ADHD score of greater than 6); Parent Inclusion Criteria:
  • Be at least 21 years old and English-speaking
  • Meet full DSM-5 criteria for ADHD (any subtype)
  • Have findings on physical examination, laboratory studies, vital signs, and electrocardiogram judged to be normal for age with no contraindications for stimulant medication
  • Have pulse and blood pressure (BP) within 95% of age and gender mean
  • Women of childbearing potential agree to use a medically accepted contraception method consistently
  • Parents with common comorbid conditions will be included provided that: (a) they do not report active suicidal ideation with intent (i.e. Beck Depression Inventory (BDI)-II score of 2 or 3 to Q9 which assesses suicidal thoughts); and (b) if receiving an antidepressant medication, their medication is well-tolerated, has not changed within 30 days, and the prescribing physician approves of their participation in the study
  • Must have regular access to a computer or phone that can be used to deliver the behavioral parent training; Parent Exclusion Criteria:
  • History of allergic or other severe negative reactions to study medications
  • Substance abuse in the past 3 months, or a positive baseline urinary toxic screen that is not explained by a time-limited medical circumstance
  • Current bipolar disorder, schizophrenia, psychoses, or other primary psychiatric disorder requiring other immediate treatment
  • History of chronic/acute medical disorder for which stimulant therapy would be contraindicated (e.g., glaucoma, hypertension)
  • Stimulant medication for ADHD in the past 30 days
  • Is pregnant

Where in United States

  • University of MarylandCollege Park, United States

About the trial

What the trial wants to find out

This study will compare the effectiveness of combined parental stimulant medication and behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and parental ADHD impairment, parental ADHD symptoms, parenting, and BPT engagement (parental outcomes/target mechanisms). This study will also assess the care delivery context and develop an implementation approach for treatment of families with a parent with ADHD and a child with elevated ADHD symptoms via telehealth in primary care sites providing pediatric care.

The 2 groups in the trial

  • Parent Stimulant Medication + Child Treatment StrategyTreatment being tested

    Parent stimulant medication first followed by a child treatment strategy consisting of behavioral parent training followed by a recommendation for child stimulant medication to the primary care provider if the child remains impaired.

    Treatment: Behavioral Parent Training and Extended release mixed amphetamine salts (MAS)

  • Child Treatment StrategyExisting treatment, for comparison

    Child treatment strategy consisting of behavioral parent training followed by a recommendation for child stimulant medication to the primary care provider if the child remains impaired. In this arm, parents do not receive stimulant medication before behavioral parent training.

    Treatment: Behavioral Parent Training

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
2/2 Treating Mothers With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
Publications
Record updated
16 September 2026